Larvol Delta - Altimmune-Completes-Enrollment-in-Phase-2b-IMPACT-Trial-of-Pemvidutide-in-Metabolic-DysfunctionAssociated-Steatohepatitis-MASH

pemvidutide (ALT-801) - Altimmune

https://www.globenewswire.com/news-release/2024/09/30/2955092/0/en/Altimmune-Completes-Enrollment-in-Phase-2b-IMPACT-Trial-of-Pemvidutide-in-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH.html

Sep 30, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next